Clinical Trials List
2017-09-01 - 2023-04-30
Phase III
Terminated3
ICD-10C50
Malignant neoplasm of breast
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ta-Chung Chao Division of Hematology & Oncology
- Yi-Fang Tsai Division of General Surgery
- 林燕淑 Division of General Surgery
- 邱仁輝 Division of General Surgery
- 賴亦貞 Division of Radiology
- 金光亮 Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
7 Terminated
Audit
None
The Actual Total Number of Participants Enrolled
0 Terminated
Taiwan National PI
Co-Principal Investigator
- 周旭桓 Division of General Surgery
- Wen-Ling Kuo Division of General Surgery
- 翁世樺 Division of Others
- 沈士哲 Division of General Surgery
- Chi-Chang Yu Division of General Surgery
- Wen-Chi Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
5 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
304 participants
